Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study - Concepedia

Concepedia

Publication | Closed Access

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study

35

Citations

26

References

2001

Year

Stylianos Kakolyris, E. Papadakis, Xanthi Tsiafaki, Aggeliki Rapti, M. Toubis, Eleni Bania, Ch. Kouroussis, Kyriakos Chainis, N. Androulakis, Sofia Agelaki,

Second-line TreatmentOncologyRhg-csf SupportMedicinePharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyLung Cancer

References

	Year	Citations

Page 1

Page 1